Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Big bid at 21

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Aug 16, 2021 2:43pm

288 Views

Post# 33711135

RE:Big bid at 21

Any price below .40 is probably a great entry pount if they pull off a global deal for TFC-1067. New investors could be very fortunate with a perfect timing, or not. The problem is the IF.

If they are successful to nail a deal.

If the deal is very profitable to reflect the risk of investing in a biotech junior.

<< Previous

Bullboard Posts

Next >>

Gold Flora's Gramlin holds court in California cannabis market